Medición de la extensión del infarto por resonancia magnética contrastada en pacientes sometidos a ACTP primaria con y sin empleo de dispositivos de aspiración de trombo como terapia adjunta
Contenido principal del artículo
Resumen
La angioplastia coronaria transluminal percutánea (ACTP) temprana durante la fase aguda del infarto agudo del miocardio (IAM) ha demostrado ser la terapéutica más eficaz para rescatar tejido miocárdico y mejorar los resultados clínicos; sin embargo, las alteraciones en la microcirculación continúan siendo comunes pese al desarrollo de nuevas estrategias terapéuticas.
Detalles del artículo
Sección
Cómo citar
Referencias
Stone GW, Grines CL, Cox DA, et al. Comparison of angioplas- ty with stenting, with and without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346: 957.
Bhatt DL, Topol EJ, et al. Does creatinine kinase-MB eleva- tion after percutaneous coronary intervention predict outcomes in Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation 2005; 112: 906-15.
Henriques JP, Zijlstra F, Ottervanger JP, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23: 1112-17.
Poli A, Fetiveau R, Vandoni P, et. Al. Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation 2002; 106: 313-18.
Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarc- tion. Circulation 1996; 93: 223-8.
Stone GW, Peterson MA, Lansky AJ, et al. Impact of norma- lized myocardial perfusion after successful angioplasty in acute myo- cardial infarction. J Am Coll Cardiol 2002; 39: 591-7.
Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. NEngl J Med 2007; 357: 1121-35.
Van 't Hof AW, Liem A, Suryapranata H, et. Al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwo- lle Myocardial Infarction Study Group. Circulation 1998; 97: 2302-6.
Van 't Hof AW, Liem A, de Boer MJ, et al. Clinical value of 12lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial Infarction Study Group. Lancet 1997; 350: 615-19.
Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eu Heart J 2008; 29: 2989-3001.
Lipiecki J, Monzy S, Durel N. Effect of thrombus aspiration on infarct size and left ventricular function in high-risk patients with acute myocardial infarction treated by percutaneous coronary inter- vention. Am Heart J 2009; 157: 583.
Burzotta F, Trani C, Romagnoli E. Manual Thrombus-Aspira- tion Improves Myocardial Reperfusion. The Randomized Evaluation
of the Effect of Mechanical Reduction of Distal Embolization by Thrombus-Aspiration in Primary and Rescue Angioplasty (REME- DIA) Trial. J Am Coll Cardiol 2005; 46(2): 371-6.
Gibbons RJ, Miller TD, Christian TF. Infarct size measured by single photon emission computed tomographic imaging with 99mT csestamibi: a measure of the efficacy of therapy in acute myocardial infarction. Circulation 2000; 101: 101-8.
Califf RM, Harrelson-Woodlief L, Topol EJ. Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials. Circulation 1990; 82: 1847-53.
Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001; 357: 21-8.
Petersen SE, Horstick G, Voigtlander T, et al. Diagnostic value of routine clinical parameters in acute myocardial infarction: a comparison to delayed contrast enhanced magnetic resonance ima- ging. Delayed enhancement and routine clinical parameters after myocardial infarction. Int J Cardiovasc Imaging 2003; 19: 409-16.
Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in con- tractile function. Circulation 2001; 104: 1101-7.
Martin TN, Groenning BA, Steedman T, et al. A single tropo- nin Iconcentration measured 12 hours after onset of chest pain accurately reflects infarct size as measured by gadolinium-DTPA late enhancement magnetic resonance imaging. J Am Coll Cardiol 2003;
: 380-1.
Hoe V, Vanderheyden M. Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization. Am J Roentgenol 2004; 182: 95-100.
Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocar- dial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105: 162-7.
Kuhl HP, Beek AM, van der Weerdt AP, et al. Myocardial viability in chronic ischemic heart disease: comparison of contrast- enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003; 41: 1341-8.
Hoe V, Vanderheyden M. Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization. Am J Roentgenol 2004; 182: 95-100.
Sandstede JJ, Lipke C, Beer M, et al. Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocar- dium on MR imaging: use in the prediction of myocardial viability. AJR Am J Roentgenol 2000; 174: 1737-40.
Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dys- function. N Engl J Med 2000; 343: 1445-53.
Knuesel PR, Nanz D, Wyss C, et al. Characterization of dys- functional myocardium by positron emission tomography and mag- netic resonance. Circulation 2003; 108: 1095-100.)
Gerber BL, Garot J, Bluemke DA, et al. Accuracy of contrast- enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial in- farction. Circulation 2002; 106: 1083-9.
Motoyasu M, Sakuma H, Ichikawa Y, et al. Prediction of
regional functional recovery after acute myocardial infarction with low dose dobutamine stress cine MR imaging and contrast enhanced MR imaging. J Cardiovasc Magn Reson 2003; 5: 563-74.
Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrastenhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003; 42: 895-901.
Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significan- ce of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97:
-72.
Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocar- dial infarcts: an imaging study. Lancet 2003; 361: 374-9.
Kitagawa K, Sakuma H, Hirano T, et. Al. Acute myocardial infarction: myocardial viability assessment in patients early thereaf- ter comparison of contrast-enhanced MR imaging with resting (201)Tl SPECT. Single photon emission computed tomography. Radiology
; 226: 138-44.
Tarantini G, Cacciavillani L, Corbetti F, et al. Duration of ischemia is a major determinant of transmurality and severe micro- vascular obstruction after primary angioplasty a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol 2005;
(7): 1229-35.
Newby LK, Rutsch WR, Califf RM, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol 1996; 27: 1646-55.
De Luca G, Suryapranata H, Ottervanger JP, et l. Time delay to treatment and mortality in primary angioplasty for acute myocar- dial infarction: every minute of delay count. Circulation 2004; 109:1223-5.
Thygesen K, Alpert JS, Harvey D, et al. Joint ESC/ACCF/ AHA/WHF Task Force for the Redefinition of Myocardial Infarc- tion. Universal definition of myocardial infarction. Eu Heart J 2007;
: 2525-38.
Sianos G, Papafaklis MI, Serruys PW, et al. Angiographic Thrombus Burden Classification in Patients With ST-Segment Ele- vation Myocardial Infarction Treated With Percutaneous Coronary Intervention. J Invasive Cardiol 2010; 22: 6-14.
Kushner FG, Hand M, et al. Focused Updates: ACC/AHA Gui- delines for the Management of Patients With ST-Elevation Myocar- dial Infarction (Updating the 2004 Guideline and 2007 Focused Up- date) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary In- tervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/Ameri- can Heart Association Task Force on Practice Guidelines. JACC Vol.
, No. 23, 2009. December 1, 2009:2205-41.
Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST segment elevation. Eu Heart J 2008; 29: 2909-45.
Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med
; 357: 2001-15.
Desch S, Engelhardt H, Meissner J. Reliability of myocardial salva- ge assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction. Int J Cardiovasc Imaging 2012; 28(2): 263-72.